2m 2m 2m 2m 2m 2m 2m
MONOPAR THERAPE (MNPR)
NASDAQ
$77.84-$0.13 (-0.17%)
Price as of Oct 02, 2026 4:27 PM EDT- $523.3MMarket Cap
- -19.79%1-Year Change
- BiotechnologyIndustry
MONOPAR THERAPE (MNPR)
$77.84-$0.13 (-0.17%)
MNPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $77.97 | ||
Change | -$1.70 (-2.13%) | ||
Open | $79.64 | ||
High | $80.33 | ||
Low | $77.59 | ||
Previous Close | $79.67 | ||
Volume | 130,810 | ||
30-Day Average Volume | 151,266 | ||
1-Week Change | -12.24% | ||
1-Month Change | -33.68% | ||
1-Year Change | -19.79% | ||
3-Year Change | 2,415.57% | ||
5-Year Change | 239.00% | ||
Fundamentals | |||
Shares Outstanding | 6.7M | ||
Total Assets | $135.0M | ||
Market Cap | $523.3M | ||
Enterprise Value | $470.6M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$5.3M | ||
Free Cash Flow | -$3.2M | ||
EBIT | -$5.3M | ||
EBITDA | -$5.3M | ||
Net Working Capital | $130.7M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -89 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -126 | ||
PEG | 4 | ||
Price/Free Cash Flow | -161 | ||
Price/Operating Cash Flow | -161 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 08/13/2024 | ||
Earnings & Revenue